A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma

被引:5
|
作者
Jabulowsky, Robert A.
Loquai, Carmen
Diken, Mustafa
Kranz, Lena M.
Haas, Heinrich
Attig, Sebastian
Bidmon, Nicole
Buck, Janina
Derhovanessian, Evelyne
Diekmann, Jan
Fritz, Daniel
Jahndel, Veronika
Kemmer-Brueck, Alexandra
Kuehlcke, Klaus
Kuhn, Andreas N.
Langguth, Peter
Luxemburger, Ulrich
Meng, Martin
Mueller, Felicitas
Rae, Richard
Sari, Fatih
Schwarck-Kokarakis, Doreen
Seck, Christine
Spiess, Kristina
Witt, Meike
Hassel, Jessica C.
Utikal, Jochen
Kaufmann, Roland
Kreiter, Sebastian
Huber, Christoph
Tuereci, Oezlem
Sahin, Ugur
机构
关键词
D O I
10.1158/1538-7445.AM2016-CT032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT032
引用
收藏
页数:4
相关论文
共 50 条
  • [1] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy
    Jabulowsky, Robert A.
    Loquai, Carmen
    Utikal, Jochen
    Hassel, Jessica
    Kaufmann, Roland
    Derhovanessian, Evelyna
    Diken, Mustafa
    Kranz, Lena M.
    Haas, Heinrich
    Attig, Sebastian
    Anft, Christine
    Buck, Janina
    Diekmann, Jan
    Fritz, Daniel
    Hartmann, Kerstin
    Kemmer-Brueck, Alexandra
    Kuehlcke, Klaus
    Kuhn, Andreas N.
    Langguth, Peter
    Luxemburger, Ulrich
    Meng, Martin
    Rae, Richard
    Sari, Fatih
    Schwarck-Kokarakis, Doreen
    Stein, Malte
    Grabbe, Stephan
    Kreiter, Sebastian
    Tuereci, Oezlem
    Huber, Christoph
    Sahin, Ugur
    CANCER RESEARCH, 2017, 77
  • [2] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy
    Heesen, L.
    Jabulowsky, R.
    Loquai, C.
    Utikal, J.
    Gebhardt, C.
    Hassel, J.
    Kaufmann, R.
    Pinter, A.
    Derhovanessian, E.
    Diken, M.
    Kranz, L.
    Haas, H.
    Attig, S.
    Kuhn, A.
    Langguth, P.
    Schwarck-Kokarakis, D.
    Jaeger, D.
    Grabbe, S.
    Tuereci, Oe.
    Sahin, U.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
    Jabulowsky, R. A.
    Loquai, C.
    Derhovanessian, E.
    Mitzel-Rink, H.
    Utikal, J.
    Hassel, J.
    Kaufmann, R.
    Pinter, A.
    Diken, M.
    Gold, M.
    Heesen, L.
    Schreeb, K. H.
    Schwarck-Kokarakis, D.
    Kreiter, S.
    Gaiser, M. R.
    Jaeger, D.
    Grabbe, S.
    Tuereci, O.
    Sahin, U.
    ANNALS OF ONCOLOGY, 2018, 29 : 439 - 439
  • [4] A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma
    Jabulowsky, Robert A.
    Loquai, Carmen
    Mitzel-Rink, Heidrun
    Utikal, Jochen
    Gebhardt, Christoffer
    Hassel, Jessica C.
    Kaufmann, Roland
    Pinter, Andreas
    Derhovanessian, Evelyna
    Anft, Christine
    Attig, Sebastian
    Deubel, Alexandra
    Diken, Mustafa
    Gold, Maike
    Guertler, Claudia
    Haas, Heinrich
    Heesen, Ludwig
    Kemmer-Brueck, Alexandra
    Kranz, Lena M.
    Kuehlcke, Klaus
    Kuhn, Andreas
    Langguth, Peter
    Luxemburger, Ulrich
    Maurus, Daniel
    Meng, Martin
    Mueller, Felicitas
    Rae, Richard
    Sari, Fatih
    Schreeb, Katharina
    Schwarck-Kokarakis, Doreen
    Stein, Malte
    Jaeger, Dirk
    Grabbe, Stephan
    Kreiter, Sebastian
    Huber, Christoph
    Tuereci, Oezlem
    Sahin, Ugur
    CANCER RESEARCH, 2018, 78 (13)
  • [5] A FIRST-IN-HUMAN (FIH) PHASE I/IIA CLINICAL TRIAL ASSESSING A RIBONUCLEIC ACID LIPOPLEX (RNA-LPX) ENCODING SHARED TUMOR ANTIGENS FOR IMMUNOTHERAPY OF PROSTATE CANCER; PRELIMINARY ANALYSIS OF PRO-MERIT
    Linch, Mark
    Papai, Zsuzsanna
    Takacs, Istvan
    Imedio, Esteban Rodrigo
    Kuhnle, Marie-Cristine
    Derhovanessian, Evelyna
    Vogler, Isabel
    Renken, Stephanie
    Graham, Philippa
    Sahin, Ugur
    Tureci, Ozlem
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A451 - A451
  • [6] FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION
    Lysandrou, Memnon
    Kefala, Dionysia
    Christofi, Panagiota
    Liga, Maria
    Miggos, Antonis
    Papagregoriou, Charys
    Vlachonikola, Elisavet
    Savvopoulos, Nikolaos
    Zacharioudaki, Vassiliki
    Vallianou, Ioanna
    Sagiadinou, Eleutheria
    Tsokanas, Dimitris
    Theodorellou, Rodanthy
    Papadopoulou, Anastasia
    Triantafyllou, Evi
    Sakellari, Ioanna
    Costeas, Paul
    Chatzidimitriou, Anastasia
    Yannaki, Evangelia
    Spyridonidis, Alexandros
    BONE MARROW TRANSPLANTATION, 2024, 59 : 534 - 535
  • [7] FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION
    Lysandrou, M.
    Kefala, D.
    Christofi, P.
    Liga, M.
    Miggos, A.
    Papagregoriou, C.
    Vlachonikola, E.
    Savvopoulos, N.
    Zacharioudaki, V.
    Vallianou, I.
    Sagiadinou, E.
    Tsokanas, D.
    Theodorelou, R.
    Papadopoulou, A.
    Triantafyllou, E.
    Sakellari, I.
    Costeas, P.
    Chatzidimitriou, A.
    Yannaki, E.
    Spyridonidis, A.
    CYTOTHERAPY, 2024, 26 (06) : S12 - S12
  • [8] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [9] A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.
    MacPherson, I. R.
    Bissett, D.
    Petty, R. D.
    Tait, B.
    Samuel, L. M.
    MacDonald, J.
    Smith, M.
    Birse-Archbold, J. A.
    Barnett, A. L.
    Wolf, C. R.
    Elcombe, C. R.
    Jeynes-Ellis, A.
    Evans, T. R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial
    Streby, Keri A.
    Currier, Mark A.
    Triplet, Melinda
    Ott, Kristy
    Dishman, Devon J.
    Vaughan, Michele R.
    Ranalli, Mark A.
    Setty, Bhuvana
    Skeens, Micah A.
    Whiteside, Stacy
    Yeager, Nicholas D.
    Haworth, Kellie B.
    Simpson, Kathleen
    Conner, Joe
    Cripe, Timothy P.
    MOLECULAR THERAPY, 2019, 27 (11) : 1930 - 1938